Skip to Content
Merck
CN
All Photos(4)

Key Documents

View All Documentation

Safety Information

372781

Sigma-Aldrich

Poly(ethylene oxide)

average MV 1,000,000 (nominal), powder, hydroxyl, BHT as inhibitor

Synonym(s):

Polyethylene oxide, PEO

Sign Into View Organizational & Contract Pricing

Select a Size

All Photos(4)

Select a Size

Change View

About This Item

Linear Formula:
(-CH2CH2O-)n
CAS Number:
25322-68-3
MDL number:
MFCD00081839
UNSPSC Code:
12352104
PubChem Substance ID:
24863166
NACRES:
NA.23

Product Name

Poly(ethylene oxide), average Mv ~1,000,000 (nominal), powder

form

powder

Quality Level

200

mol wt

average Mv ~1,000,000 (nominal)

contains

200-500 ppm BHT as inhibitor

viscosity

400-800 cP, 2 % in H2O(25 °C, Brookfield)(lit.)

functional group

hydroxyl

SMILES string

[H]OCCO

InChI

1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2

InChI key

LYCAIKOWRPUZTN-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Poly(ethylene oxide) (PEO) is a crystalline, thermoplastic, water-soluble polymer that is commercially available.[1]

Application

PEO (Mv ~ 1,000,000, powder) can be used in the fabrication of hollow TiO2 fibers, which can be used for a variety of applications such as drug delivery, catalysts, sensors, and electric devices.[1] It can also be used as an electrolyte for the formation of dye-sensitized solar cells (DSSCs).[2]

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

易制毒化学品（3类）
危险化学品

    • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number
    MKCX9961
    MKCX9960
    0000433844
    0000433844
    0000312248

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Search for a COA

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Issues in Pharmacology, Pharmacy, Drug Research, and Drug Innovation: 2011 Edition (2012)
    Yang Cao et al.
    British journal of haematology, 168(5), 701-707 (2014-11-06)
    CXCR4(WHIM) frameshift and nonsense mutations follow MYD88(L265P) as the most common somatic variants in Waldenström Macroglobulinaemia (WM), and impact clinical presentation and ibrutinib response. While the nonsense (CXCR4(S338X) ) mutation has been investigated, little is known about CXCR4 frameshift (CXCR4(FS)
    Federico Mele et al.
    Nature communications, 6, 6431-6431 (2015-03-17)
    T helper (TH) cell polarization during priming is modulated by a number of signals, but whether polarization to a given phenotype also influences recall responses of memory TH cells is relatively unknown. Here we show that miR-181a is selectively induced
    Inna V Fedorenko et al.
    Proteomics, 15(2-3), 327-339 (2014-10-24)
    Basal and kinase inhibitor driven adaptive signaling has been examined in a panel of melanoma cell lines using phosphoproteomics in conjunction with pathway analysis. A considerable divergence in the spectrum of tyrosine-phosphorylated peptides was noted at the cell line level.
    L Schafranek et al.
    Leukemia, 29(1), 76-85 (2014-05-13)
    Kinase inhibitors block proliferative signals in BCR-ABL1+ leukemic cells, but their capacity to induce apoptosis is poorly understood. Initial studies suggested that very brief exposure to kinase inhibitors was sufficient to induce apoptosis in chronic myeloid leukemia (CML) cells. However
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service